Weekly testing enables rapid suppression of outbreaks even with widespread community transmission. Control of outbreaks through social distancing and surveillance testing lead to further reductions in testing frequency.
Data from Helix’s research community is helping scientists around the world, including a recent finding published in the New England Journal of Medicine.
Our team of researchers are currently working through the data, but we have already found some interesting insights in our collection of survey responses, and we’ve contributed our findings to a worldwide research effort, consisting of renowned scientists from around the globe. These results, described below, highlight the power of population health studies and the impact of sharing information early and often.
Helix researchers, along with collaborators from Renown Health and UC San Diego, found that, relative to nasopharyngeal swabs, the sensitivity of saliva was approximately 30% lower in a community-based diagnostic cohort and 50% lower in a convalescent cohort
Over the next several days, Helix researchers will be reaching out to hundreds of thousands of people—each of them having already had their DNA sequenced by Helix—with a short survey. The survey collects information about a person’s possible exposure to COVID-19, any symptoms (or lack thereof) that they may be experiencing, and any medications they … Read more
Helix researchers to leverage user input and exome-sequencing data to understand COVID-19 risk and severity The spread of the novel SARS-CoV-2 coronavirus has led to the unfolding COVID-19 pandemic. In addition to demonstrating a high degree of transmissibility, a significant barrier to the treatment and containment of this virus has been the variability in symptoms … Read more
Revealing variants in SARS-CoV-2 interaction domain of ACE2 and loss of function intolerance through analysis of >200,000 exomes
Our analysis suggests that variants in the ACE2 gene–particularly those in the regions that interact with the SARs-COV-2 virus–have the potential to show important associations with COVID-19 susceptibility and resistance.
Helix’s Exome+ assay has been carefully optimized to provide the benefits of targeted panels and the completeness of whole exome sequencing.
If you’ve had a chance to take in a stage or two of this year’s Tour de France, maybe you’ve found yourself wondering: is it in their genes? The cyclists—or superhumans!—who take on the Tour deal with extreme climbs and harrowing descents, spanning more than 2,000 miles along routes that include the Alps and Pyrenees … Read more